(Q34119530)

31 July 2017

Anti-oxidant therapy for the treatment of coronary artery disease (English)

1 reference

31 July 2017

coronary artery disease

1 reference

Kendall MJ

1

1 reference

PubMed ID

11139823

31 July 2017

Nuttall SL

series ordinal

2

1 reference

PubMed ID

11139823

31 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Expert Opinion on Investigational Drugs

31 July 2017

1 reference

31 July 2017

8

1 reference

31 July 2017

11

1 reference

31 July 2017

1763-1784

1 reference

Mortality by cause for eight regions of the world: Global Burden of Disease Study

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Myth and paradox of coronary risk and the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Beta-blockers and sudden cardiac death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Aspirin as an antiplatelet drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

The primary prevention of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Smoking and death: the past 40 years and the next 40

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Smoking and risk of myocardial infarction in women and men: longitudinal population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Body weight: implications for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Cohort study of effect of being overweight and change in weight on risk of coronary heart disease in old age

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Physical activity and health

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Non-pharmacological modification of cardiac risk factors: Part 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Randomised controlled trial of effect of fruit and vegetable consumption on plasma concentrations of lipids and antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Free radicals and antioxidants in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Antioxidants and atherosclerotic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Passive smoking, coronary heart disease, and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Dietary habits and mortality in 11,000 vegetarians and health conscious people: results of a 17 year follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Wine, alcohol, platelets, and the French paradox for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Tea consumption. relationship to cholesterol, blood pressure, and coronary and total mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Mechanisms of hypochlorite injury of target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Free radicals in disease processes: a compilation of cause and consequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

LDL particle size: an important drug target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

The transport of vitamin C and effects of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Free-radical scavenging activities, interactions and recycling of antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Direct observation of a free radical interaction between vitamin E and vitamin C

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

The redox couple between glutathione and ascorbic acid: a chemical and physiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Iodometric measurement of lipid hydroperoxides in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Phycoerythrin fluorescence-based assay for peroxy radicals: a screen for biologically relevant protective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Flavonoids as superoxide scavengers and antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Homocysteine and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

The oxidant stress of hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Antioxidant therapy for the prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Probucol as an antioxidant and antiatherogenic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Captopril: a free radical scavenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Vitamin E consumption and the risk of coronary disease in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Vitamin E consumption and the risk of coronary heart disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Oxidative stress after thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1763

10.1517/13543784.8.11.1763

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11139823